Meridian Bioscience receives U.S. FDA Emergency Use Authorization for Revogene SARS-CoV-2 molecular assay
The company expects to begin shipping this product before the end of its fiscal first quarter, ending December 31, 2021
The company expects to begin shipping this product before the end of its fiscal first quarter, ending December 31, 2021
LSDCheck is CE-IVD approved LCMSMS-based testing kit for LSD in newborns
New bioinformatic workflow advances analysis capabilities for whole-exome assessment and interpretation
It provides an option to automatically perform nodule detection immediately after chest X-ray imaging
Through the mission an entire ecosystem for services from treatment to critical research will be created in every corner of the country
This strategic collaboration will enable continued innovation in cancer care
The test kit uses a reagent developed using Kaneka's molecular testing-related technologies
RT-PCR test detects and differentiates SARS-CoV-2, influenza A, influenza B and respiratory syncytial virus
FUJIFILM will distribute iSWAB bio sampling technologies in Japan
Remote screening of diabetic retinopathy can help in early detection, even before there are any noticeable vision changes
Subscribe To Our Newsletter & Stay Updated